CIK 0001374690
- Non-accelerated filer
- Smaller reporting company
Larimar Therapeutics, Inc.
Sign in to watch- Ticker
- LRMR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 203857670
- Phone
- +1 844-511-9056
- Business address
- THREE BALA PLAZA EAST. SUITE 506, BALA CYNWYD, PA, 19004
- Former names
- ZAFGEN, INC., ZAFGEN INC
- Open-market buys, last 90 days
- $392,144
- in 8 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$392,144. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 30 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2015-09-24 | STARR KEVIN P Director | Other disposition | −476,170 | 0 | ||
| 2015-09-24 | STARR KEVIN P Director | Other acquisition | +98,834 | 370,323 | ||
| 2015-09-23 | Hughes Thomas E. Chief Executive Officer | Option exercise | +10,500 | $0.75 | $8K | 11,320 |
| 2015-09-23 | Hughes Thomas E. Chief Executive Officer | Option exercise · Stock Option (Right to Buy) | −10,500 | 53,928 | ||
| 2015-09-18 | Hughes Thomas E. Chief Executive Officer | Option exercise | +23,126 | $2.45 | $57K | 23,946 |
| 2015-09-18 | Hughes Thomas E. Chief Executive Officer | Sale | −23,126 | $45.00 | $1.0M | 820 |
| 2015-09-18 | Hughes Thomas E. Chief Executive Officer | Option exercise · Stock Option (Right to Buy) | −23,126 | 160,555 | ||
| 2015-09-18 | Goldberg Avi Y. Director | Sale | −5,000 | $45.00 | $225K | 53,734 |
| 2015-09-17 | KIM DENNIS D Chief Medical Officer | Sale | −9,142 | $40.00 | $366K | 0 |
| 2015-09-17 | Hughes Thomas E. Chief Executive Officer | Option exercise | +4,874 | $2.45 | $12K | 23,320 |
| 2015-09-17 | Hughes Thomas E. Chief Executive Officer | Sale | −22,500 | $40.00 | $900K | 820 |
| 2015-09-17 | Hughes Thomas E. Chief Executive Officer | Option exercise · Stock Option (Right to Buy) | −4,874 | 183,681 | ||
| 2015-09-17 | Secor Alicia Chief Commercial Officer | Option exercise | +25,000 | $9.67 | $242K | 26,256 |
| 2015-09-17 | Secor Alicia Chief Commercial Officer | Sale | −25,000 | $41.05 | $1.0M | 1,256 |
| 2015-09-17 | Secor Alicia Chief Commercial Officer | Sale | −1,256 | $41.05 | $52K | 0 |
| 2015-09-17 | Secor Alicia Chief Commercial Officer | Option exercise · Stock Option (Right to Buy) | −25,000 | 134,235 | ||
| 2015-09-17 | KIM DENNIS D Chief Medical Officer | Option exercise | +9,142 | $1.57 | $14K | 9,142 |
| 2015-09-17 | KIM DENNIS D Chief Medical Officer | Sale | −9,142 | $40.00 | $366K | 0 |
| 2015-09-17 | KIM DENNIS D Chief Medical Officer | Option exercise · Stock Option (Right to Buy) | −9,142 | 103,312 | ||
| 2015-09-15 | KIM DENNIS D Chief Medical Officer | Sale | −30,265 | $40.00 | $1.2M | 0 |
Page 14 of 15 · 296 trades